Sangiovanni Timothy J. 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Transactions
- Sale
Common Stock
2025-02-13$7.86/sh−3,000$23,588→ 16,341 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 10-15-2024